Skip to main content
Premium Trial:

Request an Annual Quote

Luminex May Pick New CFO Next Week

NEW YORK, March 12 - Luminex may pick a new money man as early as next week.

An official at the Austin, Texas-based bead-array developer told GenomeWeb on Wednesday that the company's board may name a new chief financial officer at a meeting next week.

Luminex said in a terse memo released on March 4 that CFO Frank Reeves had left the company after less than one year on the job. In an interview today, Randy Marfin, vice president of business development, said the abrupt departure was due to personal rather than performance-related reasons.


Harriss Currie, acting controller and treasure at Luminex, has been interim CFO, Marvin said. Currie, 40, who has been helped by Kevin McNamara, a corporate consultant, will likely get the nod to take over Reeves' post full time.
"Harriss has been acting as a CFO and it's quite possible that he could be the CFO," said Marvin.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.